DigestAID - Digestive Artificial Intelligence Development published the research article Artificial Intelligence for Anal Cancer Screening: Multicenter Multicontinental Validation of a Trinary Model in High-Resolution Anoscopy in Gastro Hep Advances.
Published
Signal category
Research & Knowledge
Quote
“We are proud to share the publication of our latest research, “Artificial Intelligence for Anal Cancer Screening: Multicenter Multicontinental Validation of a Trinary Model in High-Resolution Anoscopy,” in Gastro Hep Advances.”
— DIGESTAID - Digestive Artificial Intelligence Development team
Company
- Industry
- Medical Equipment Manufacturing
- Location
- Porto, PT
- Company size
- 46 employees
DIGESTAID – Digestive Artificial Intelligence Development – is a company dedicated to the development of AI platforms with the aim of improving digestive healthcare. Our team of physicians, software engineers and data scientists strive to produce deep learning solutions for automatic detection and characterization of lesions across different fields of Gastroenterology and Digestive Endoscopy, supporting the physician in the decision process. Our highly motivated and multidisciplinary team mainly focus in a non-invasive AI lesion detection/differentiation software solution for the entirety of the digestive tube as well as pancreatobiliary lesion characterization. Our main goals are to improve diagnostic accuracy, reduce medical error, improve workflow efficiency, reduce costs while ultimately contributing to improve patient experience and outcome. Our motto is to provide higher accuracy in digestive endoscopy, improved medical decisions and to spare time and valuable health human resources